| Name | Title | Contact Details |
|---|
ECD Systems, Inc. is a Marstons Mills, MA-based company in the Software and Internet sector.
Founded in 2008 by CEO Sam Barnett, Struq is the leading Cross Device Retargeting and ad personalization platform. Struq enables e-commerce businesses to increase their sales through highly-targeted, personalized remarketing and prospecting ad campaigns across display, video, social media and mobile channels. Struq’s industry-leading Cross Device Retargeting technology allows retailers to re-find 40-60% of their users on another device with 100% accuracy. Building up a holistic picture of a user and serving them fully personalized ads across all devices allows for the maximization of sales and conversions. Struq works with 350 of the world’s largest brands across 19 territories, including Topshop, Levi’s, Uniqlo, Esprit, Debenhams, Tesco Direct, Hotels.com and easyJet. We are a truly global company, with offices in London, New York, Brazil and Turkey.
InfoHedge Technologies is a New York, NY-based company in the Software and Internet sector.
Trust Bearer Labs is a Fort Wayne, IN-based company in the Software and Internet sector.
As the Device Benefit Management (DBM) leader, IPG provides transparent end-to-end implant management and predictive analytical solutions, establishing the industry standard around cost, quality and safety to drive accessibility and affordability of care. The company has pioneered a unique DBM model which streamlines the management and delivery of implantable devices by working directly with health plans, clinical providers, facilities and medical device manufacturers. IPG delivers implant intelligence surrounding the overall cost and quality of healthcare being delivered, adding transparency and predictability of spend in tandem with the implementation of quality and safety metrics necessary to drive and reward best practices. Through collaborative partnerships that drive physician alignment, and employer and patient satisfaction, this approach ensures that patients receive increased access to affordable and innovative life-saving and life-enhancing device-intensive medical therapies.